These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32100015)

  • 41. Case Study: Systematic Detection and Prioritization of Gene Fusions in Cancer by RNA-Seq: A DIY Toolkit.
    Vats P; Chinnaiyan AM; Kumar-Sinha C
    Methods Mol Biol; 2020; 2079():69-79. PubMed ID: 31728962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors.
    Conroy JM; Pabla S; Glenn ST; Burgher B; Nesline M; Papanicolau-Sengos A; Andreas J; Giamo V; Lenzo FL; Hyland FCL; Omilian A; Bshara W; Qin M; He J; Puzanov I; Ernstoff MS; Gardner M; Galluzzi L; Morrison C
    J Mol Diagn; 2018 Jan; 20(1):95-109. PubMed ID: 29061374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expanding the Clinical Utility of Targeted RNA Sequencing Panels beyond Gene Fusions to Complex, Intragenic Structural Rearrangements.
    Schieffer KM; Moccia A; Bucknor BA; Stonerock E; Jayaraman V; Jenkins H; McKinney A; Koo SC; Mathew MT; Mardis ER; Lee K; Reshmi SC; Cottrell CE
    Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GFusion: an Effective Algorithm to Identify Fusion Genes from Cancer RNA-Seq Data.
    Zhao J; Chen Q; Wu J; Han P; Song X
    Sci Rep; 2017 Jul; 7(1):6880. PubMed ID: 28761119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FusionCancer: a database of cancer fusion genes derived from RNA-seq data.
    Wang Y; Wu N; Liu J; Wu Z; Dong D
    Diagn Pathol; 2015 Jul; 10():131. PubMed ID: 26215638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers.
    Dehghannasiri R; Freeman DE; Jordanski M; Hsieh GL; Damljanovic A; Lehnert E; Salzman J
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15524-15533. PubMed ID: 31308241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization.
    Krystel-Whittemore M; Taylor MS; Rivera M; Lennerz JK; Le LP; Dias-Santagata D; Iafrate AJ; Deshpande V; Chebib I; Nielsen GP; Wu CL; Nardi V
    Hum Pathol; 2019 Nov; 93():65-73. PubMed ID: 31430493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Most gene fusions in cancer are stochastic events.
    Johansson B; Mertens F; Schyman T; Björk J; Mandahl N; Mitelman F
    Genes Chromosomes Cancer; 2019 Sep; 58(9):607-611. PubMed ID: 30807681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion.
    Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT
    Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
    Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
    Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumors.
    Kou T; Kanai M; Yamamoto Y; Kamada M; Nakatsui M; Sakuma T; Mochizuki H; Hiroshima A; Sugiyama A; Nakamura E; Miyake H; Minamiguchi S; Takaori K; Matsumoto S; Haga H; Seno H; Kosugi S; Okuno Y; Muto M
    Cancer Sci; 2017 Jul; 108(7):1440-1446. PubMed ID: 28440963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene Fusion Discovery with INTEGRATE.
    Zhang J; Maher CA
    Methods Mol Biol; 2020; 2079():41-68. PubMed ID: 31728961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A genomic DNA-based NGS method for the simultaneous detection of multiple fusion genes in pediatric leukemia.
    Liu R; Feng S; Li Y; Pan H; Liang C; Su Y; Dong J; Li B; Chen Z; Cui X
    Oncol Lett; 2023 Jan; 25(1):21. PubMed ID: 36466998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.
    Park K; Tran H; Eng KW; Ramazanoglu S; Marrero Rolon RM; Scognamiglio T; Borczuk A; Mosquera JM; Pan Q; Sboner A; Rubin MA; Elemento O; Rennert H; Fernandes H; Song W
    Arch Pathol Lab Med; 2020 Dec; 144(12):1535-1546. PubMed ID: 32045275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays.
    Kadri S; Long BC; Mujacic I; Zhen CJ; Wurst MN; Sharma S; McDonald N; Niu N; Benhamed S; Tuteja JH; Seiwert TY; White KP; McNerney ME; Fitzpatrick C; Wang YL; Furtado LV; Segal JP
    J Mol Diagn; 2017 Jan; 19(1):43-56. PubMed ID: 27836695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas.
    Bret D; Chappuis V; Poncet D; Ducray F; Silva K; Mion F; Vasiljevic A; Ferraro-Peyret C; Mottolese C; Leblond P; Gabut M; Frappaz D; Streichenberger N; Meyronet D; Bringuier PP; Barritault M
    Mol Diagn Ther; 2019 Aug; 23(4):537-545. PubMed ID: 31087282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating gene fusions in solid tumors - Clinical experience using an RNA based 53 gene next-generation sequencing panel.
    Selvam P; Kelly K; Hesse AN; Spitzer D; Reddi HV
    Cancer Genet; 2019 Apr; 233-234():32-42. PubMed ID: 31109592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA; Frohnauer J; Merkelbach-Bruse S; Schildhaus HU; Dimmler A; Schubert T; Boltze C; König H; Fuchs F; Sirbu H; Rieker RJ; Agaimy A; Hartmann A; Haller F
    Lung Cancer; 2014 Jun; 84(3):215-21. PubMed ID: 24674157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of Fusion Genes to Determine Minimal Residual Disease in Leukemia Using Next-Generation Sequencing.
    de Boer EN; Johansson LF; de Lange K; Bosga-Brouwer AG; van den Berg E; Sikkema-Raddatz B; van Diemen CC
    Clin Chem; 2020 Aug; 66(8):1084-1092. PubMed ID: 32613252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC.
    Li W; Liu Y; Li W; Chen L; Ying J
    J Thorac Oncol; 2020 Jul; 15(7):1223-1231. PubMed ID: 32151779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.